NT2, The answer is very simple and you may have answered your question already. The problem with HCQ is $4. Gilead wont sell its Remdesivir for $4. Covid-19 to BP is like the Goose that will laid a golden egg. It is the very same reason Leronlimab is not getting the recognition as fast as we hope. But our day will come!!